“Oh, We Bought Guidant? I Thought We Were Buying The Rough Guide To Slovakia. Our Bad.”

Sounds like Boston Scientific may end up regretting its purchase of Guidant (which they got by beating out J&J), due in part to the carried-over tort exposure due to recalled defibrillators and pacemakers.  Hey, that sounds familiar.

Of course, the suits are still, I think, relatively small in number.  But if Google AdSense is any indication, it might turn into a big case yet.